Merck could lose up to $630 million in Gardasil revenue this year now that the U.S. no longer recommends three doses of the HPV shot in the childhood vaccine schedule, according to Jefferies analysts.
The Centers for Disease Control and Prevention on Monday
announced sweeping changes to the childhood vaccine schedule. The health agency no longer recommends that all children get seven of the 18 previously recommended immunizations, and it now says that children should get one dose of the HPV vaccine instead of the two to three doses recommended on the label.
Merck could lose up to $630 million in revenue after CDC changes HPV vaccine recommendation
Published:
Merck could lose up to $630 million in Gardasil revenue this year now that the U.S. no longer recommends three doses of the HPV shot in the childhood vaccine schedule, according to Jefferies analysts.
The Centers for Disease Control and Prevention on Monday
announced sweeping changes to the childhood vaccine schedule. The health agency no longer recommends that all children get seven of the 18 previously recommended immunizations, and it now says that children should get one dose of the HPV vaccine instead of the two to three doses recommended on the label.
Share this:
Related